Increased incidence of thromboembolic events in patients with severe COVID-19 infection has been documented. Acute limb ischemia as a complication in critically ill patients due to coagulopathy has been reported, worsening prognosis and increasing limb amputation rate. Delayed recognition could lead to irreversible ischemia and clinical deterioration requiring amputation. We present the case of a 54-year-old male with severe COVID-19 infection who developed clinical deterioration and acute lower limb ischemia at day 7 of hospitalization in the intensive care unit. Skin color changes suggested necrotic tissue and skin bullae. Arterial doppler ultrasound revealed a thrombus on the distal superficial femoral artery with absence of blood flow. Irreversible ischemia was diagnosed. The patient underwent an above the knee amputation, showing favorable clinical evolution during the next three days. Nonetheless, septic shock persisted, and 14 days later the patient presented cardiorespiratory arrest and passed away. Acute limb ischemia could present as a complication in critically ill patients treated in the intensive care unit, increasing amputation rate and worsening prognosis. In patients with critical management, physical examination and laboratory analyses are essential for clinical evolution concerning peripheral vascular disease. Efforts should be made to diagnose such complications on time with a more rigorous and protocolized limb perfusion examination.
Published in | World Journal of Medical Case Reports (Volume 3, Issue 2) |
DOI | 10.11648/j.wjmcr.20220302.13 |
Page(s) | 25-28 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Limb Ischemia, Amputation, COVID-19, Septic Shock
[1] | Tedros Adhanom Ghebreyesus. No Title. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 6 August 2020. 2020. |
[2] | Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020; 34: 101623. |
[3] | The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb; 41 (2): 145–51. |
[4] | Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020 Jun; 92 (6): 568–76. |
[5] | Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 Jul; 191: 145–7. |
[6] | Lee SG, Fralick M, Sholzberg M. Coagulopathy associated with COVID-19. C Can Med Assoc J = J l’Association medicale Can. 2020 May; 192 (21): E583. |
[7] | Goldman IA, Ye K, Scheinfeld MH. Lower extremity arterial thrombosis associated with COVID-19 is characterized by greater thrombus burden and increased rate of amputation and death. Radiology. 2020 Jul; 202348. |
[8] | Mascia D, Kahlberg A, Melloni A, Rinaldi E, Melissano G, Chiesa R. Single center vascular Hub experience after 7 weeks of COVID-19 pandemic in Lombardy (Italy). Ann Vasc Surg. 2020 Aug. |
[9] | Han H, Yang L, Liu R, Liu F, Wu K-L, Li J, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020 Jun; 58 (7): 1116–20. |
[10] | Xiong M, Liang X, Wei Y-D. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Vol. 189, British journal of haematology. 2020. p. 1050–2. |
[11] | Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 Apr; 18 (4): 844–7. |
[12] | Bellosta R, Luzzani L, Natalini G, Pegorer MA, Attisani L, Cossu LG, et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020. |
[13] | Galanis N, Stavraka C, Agathangelidis F, Petsatodis E, Giankoulof C, Givissis P. Coagulopathy in COVID-19 infection: a case of acute upper limb ischemia. Vol. 2020, Journal of surgical case reports. 2020. p. rjaa204. |
[14] | Kashi M, Jacquin A, Dakhil B, Zaimi R, Mahé E, Tella E, et al. Severe arterial thrombosis associated with COVID-19 infection. Vol. 192, Thrombosis research. 2020. p. 75–7. |
[15] | Kaur P, Posimreddy S, Singh B, Qaqa F, Habib HA, Maroules M, et al. COVID-19 Presenting as Acute Limb Ischaemia. Eur J case reports Intern Med. 2020; 7 (6): 1724. |
[16] | Kaur P, Qaqa F, Ramahi A, Shamoon Y, Singhal M, Shamoon F, et al. Acute upper limb ischemia in a patient with COVID-19. Hematology/oncology and stem cell therapy. 2020. |
[17] | Schultz K, Wolf JM. Digital Ischemia in COVID-19 Patients: Case Report. J Hand Surg Am. 2020 Jun; 45 (6): 518–22. |
[18] | Vacirca A, Faggioli G, Pini R, Teutonico P, Pilato A, Gargiulo M. Unheralded Lower limb threatening ischemia in a COVID-19 patient. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020 Jul; 96: 590–2. |
[19] | Simon F, Oberhuber A, Floros N, Busch A, Wagenhäuser MU, Schelzig H, et al. Acute Limb Ischemia-Much More Than Just a Lack of Oxygen. Int J Mol Sci. 2018 Jan; 19 (2). |
APA Style
Adolfo Leyva-Alvizo, Cristina Villar-Canton, Alberto Riojas-Garza. (2022). Acute Lower Limb Ischemia in a Patient with COVID-19 and Septic Shock Requiring Amputation. World Journal of Medical Case Reports, 3(2), 25-28. https://doi.org/10.11648/j.wjmcr.20220302.13
ACS Style
Adolfo Leyva-Alvizo; Cristina Villar-Canton; Alberto Riojas-Garza. Acute Lower Limb Ischemia in a Patient with COVID-19 and Septic Shock Requiring Amputation. World J. Med. Case Rep. 2022, 3(2), 25-28. doi: 10.11648/j.wjmcr.20220302.13
@article{10.11648/j.wjmcr.20220302.13, author = {Adolfo Leyva-Alvizo and Cristina Villar-Canton and Alberto Riojas-Garza}, title = {Acute Lower Limb Ischemia in a Patient with COVID-19 and Septic Shock Requiring Amputation}, journal = {World Journal of Medical Case Reports}, volume = {3}, number = {2}, pages = {25-28}, doi = {10.11648/j.wjmcr.20220302.13}, url = {https://doi.org/10.11648/j.wjmcr.20220302.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjmcr.20220302.13}, abstract = {Increased incidence of thromboembolic events in patients with severe COVID-19 infection has been documented. Acute limb ischemia as a complication in critically ill patients due to coagulopathy has been reported, worsening prognosis and increasing limb amputation rate. Delayed recognition could lead to irreversible ischemia and clinical deterioration requiring amputation. We present the case of a 54-year-old male with severe COVID-19 infection who developed clinical deterioration and acute lower limb ischemia at day 7 of hospitalization in the intensive care unit. Skin color changes suggested necrotic tissue and skin bullae. Arterial doppler ultrasound revealed a thrombus on the distal superficial femoral artery with absence of blood flow. Irreversible ischemia was diagnosed. The patient underwent an above the knee amputation, showing favorable clinical evolution during the next three days. Nonetheless, septic shock persisted, and 14 days later the patient presented cardiorespiratory arrest and passed away. Acute limb ischemia could present as a complication in critically ill patients treated in the intensive care unit, increasing amputation rate and worsening prognosis. In patients with critical management, physical examination and laboratory analyses are essential for clinical evolution concerning peripheral vascular disease. Efforts should be made to diagnose such complications on time with a more rigorous and protocolized limb perfusion examination.}, year = {2022} }
TY - JOUR T1 - Acute Lower Limb Ischemia in a Patient with COVID-19 and Septic Shock Requiring Amputation AU - Adolfo Leyva-Alvizo AU - Cristina Villar-Canton AU - Alberto Riojas-Garza Y1 - 2022/05/10 PY - 2022 N1 - https://doi.org/10.11648/j.wjmcr.20220302.13 DO - 10.11648/j.wjmcr.20220302.13 T2 - World Journal of Medical Case Reports JF - World Journal of Medical Case Reports JO - World Journal of Medical Case Reports SP - 25 EP - 28 PB - Science Publishing Group SN - 2994-726X UR - https://doi.org/10.11648/j.wjmcr.20220302.13 AB - Increased incidence of thromboembolic events in patients with severe COVID-19 infection has been documented. Acute limb ischemia as a complication in critically ill patients due to coagulopathy has been reported, worsening prognosis and increasing limb amputation rate. Delayed recognition could lead to irreversible ischemia and clinical deterioration requiring amputation. We present the case of a 54-year-old male with severe COVID-19 infection who developed clinical deterioration and acute lower limb ischemia at day 7 of hospitalization in the intensive care unit. Skin color changes suggested necrotic tissue and skin bullae. Arterial doppler ultrasound revealed a thrombus on the distal superficial femoral artery with absence of blood flow. Irreversible ischemia was diagnosed. The patient underwent an above the knee amputation, showing favorable clinical evolution during the next three days. Nonetheless, septic shock persisted, and 14 days later the patient presented cardiorespiratory arrest and passed away. Acute limb ischemia could present as a complication in critically ill patients treated in the intensive care unit, increasing amputation rate and worsening prognosis. In patients with critical management, physical examination and laboratory analyses are essential for clinical evolution concerning peripheral vascular disease. Efforts should be made to diagnose such complications on time with a more rigorous and protocolized limb perfusion examination. VL - 3 IS - 2 ER -